Clinical Trial for Integrated Care to Help At Risk Teens (iCHART) Intervention
The Center for Enhancing Triage and Utilization for Depression and Emergent Suicidality (ETUDES) in Pediatric Primary Care-iCHART RCT
This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, anhedonia, and stress related to cyber-victimization. This study will recruit 900 adolescents which will be enrolled in a randomized controlled trial to test iCHART and will be randomized to iCHART or treatment as usual (TAU). Based on previous work, the investigators hypothesize that iCHART, compared to TAU, will decrease suicide-related events by 50%. The investigators will use implementation science methods to assess contextual factors (i.e., barriers and facilitators) and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for our predictive algorithm and iCHART to inform future implementation efforts and promote health equity.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
iCHART is an intervention that includes 3 components previously studied in within the ETUDES Center including the:
- Safety planning app for suicidal youth which enables a primary care provider to streamline the gold standard of care for those with current suicidality symptoms through an app (instead of a paper based version);
- Mental Health Screener questionnaire that gathers additional mental health symptoms, treatment preferences, and family's readiness for treatment engagement;
- Text Messages which aims to provide texts for 2-3 weeks to motivate youth to engage with the safety plan.
Aim 1. Test the effectiveness of iCHART in reducing suicide-related events at 6 months, the primary outcome, and examine mediators and moderators of treatment response. The investigators hypothesize: 1) iCHART will reduce suicide-related events; 2) Individual-, family-, and neighborhood-level risk and protective factors will moderate response; and 3) Examine a predictive algorithm to examine heterogeneity of treatment response.
Aim 2. Examine barriers, facilitators, and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for iCHART to inform future implementation efforts and promote health equity. Barriers and facilitators that span multiple levels of context (e.g., aspects of clinic workflows, provider beliefs and knowledge) are expected to be uncovered. Further, incorporating iCHART in pediatric primary care will be viewed as feasible, acceptable, and appropriate by youth and caregivers across different racial and ethnic groups.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Gibbsboro, New Jersey, United States, 08026
- Gibbsboro
-
-
Pennsylvania
-
Johnstown, Pennsylvania, United States, 15905
- Conemaugh Memorial Medical Center-Family Medicine
-
Philadelphia, Pennsylvania, United States, 19104
- CHOP Primary Care, CHOP Campus
-
Philadelphia, Pennsylvania, United States, 19128
- Roxborough
-
Philadelphia, Pennsylvania, United States, 19139
- CHOP Primary Care, Cobbs Creek
-
Philadelphia, Pennsylvania, United States, 19139
- Karabots
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC Center for Adolescent and Young Adult Health
-
Pittsburgh, Pennsylvania, United States, 15213
- Children's Community Pediatrics (CCP) of Children's Hospital of Pittsburgh UPMC
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC Family Medicine
-
Pittsburgh, Pennsylvania, United States, 15217
- Kids Plus Pediatrics (KPP)
-
Reading, Pennsylvania, United States, 19604
- Berks Community Health Center
-
Springfield, Pennsylvania, United States, 19064
- Springfield
-
West Chester, Pennsylvania, United States, 19380
- CHOP Primary Care, West Chester
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
YOUTH
- Youth will be age 12-18 and speak English.
- Youth will have current depression or suicidal behavior. Suicidal behavior for iCHART (N=900) is defined as past suicidal thoughts in the past two weeks as indicated by clinician interview or report or as indicated by responses to a standardized assessments such as the PHQ-9, PHQ-9M, ASQ, CSSRS, or Behavioral Health Screen, or seeking acute care or clinical contact for mental health crisis/problem in the past year.
-
CAREGIVERS/PARENTS
- Parents/caregivers of youth in the study must be at least 18 years old and their child must be willing to participate in the study. Caregivers/parents must be able to speak English. Parents are considered biological/adoptive parents or have court documentation that they can provide consent for research as a legal guardian of a youth. Only 1 parent/caregiver will be engaged in research, but in case 1 parent is unavailable, the other may be engaged (meaning it doesn't have to be the same parent participating in assessments/interviews throughout youth study participation).
Exclusion Criteria:
-
YOUTH
- Exclusion criteria include conditions that might impair their ability to effectively deploy ETUDES interventions, including:
- current manic or psychotic episode, presence of a life-threatening medical condition requiring immediate treatment, intellectual or developmental disability precluding comprehension of study procedure. The latter will be assessed by parental report of placement in self-contained Special Education classes, EHR review, and during the consent/assent and/or baseline to determine if the participant is not understanding research procedures.
- Participants without access to a phone and/or tablet to interact with components of the intervention that require a phone will be excluded.
-
CAREGIVERS/PARENTS
- There are no specific exclusion criteria for caregivers and providers. However, as mentioned in the inclusion criteria, caregivers will be excluded if they are not the biological parent or court-appointed guardian of the youth being interviewed.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: iCHART
iCHART is an intervention that includes 3 components previously studied in within the ETUDES Center including a:
Participants will receive psychoeducation and referral to a mental health treatment provider, if needed. |
The Safety Planning App will guide clinicians in the use of an emotion regulation and safety planning app (BRITE) to be loaded on the phone of depressed and suicidal adolescents in order to improve depression and reduce the likelihood of a suicide attempt. The Mental Health Screener is a decision support tool to guide clinicians to make a referral that reflects patient clinical needs and patient and parental treatment preferences and perceived barriers to treatment. The Text Messages is a personalized text messaging intervention for patients and parents that targets engagement with the safety plan to increase the likelihood that a depressed or suicidal patient will maintain or initiate recommended services. Participants will receive psychoeducation and referral to a mental health treatment provider, if needed. |
|
Active Comparator: Treatment As Usual (TAU)
Participants in this group will receive usual care from their clinician which may will include development of a paper safety plan. |
Participants in this group will receive usual care from their clinician which may include development of a paper safety plan. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide related event
Time Frame: Cumulative through 6-month follow up
|
Suicidal Event definition: combination of items on CSSRS + CASA: actual attempt=yes; interrupted attempt=yes; aborted attempt=yes; preparatory acts=yes; emergency referral=yes in CSSRS and include emergency referral items in CASA that are suicide related (receipt of treatment from a medical or psychiatric inpatient facility, emergency department, outpatient facility, or crisis center). Note this is a composite score. |
Cumulative through 6-month follow up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide related event
Time Frame: Cumulative through 12-month follow up
|
Suicidal Event definition: combination of items on CSSRS + CASA: actual attempt=yes; interrupted attempt=yes; aborted attempt=yes; preparatory acts=yes; emergency referral=yes in CSSRS and include emergency referral items in CASA that are suicide related (receipt of treatment from a medical or psychiatric inpatient facility, emergency department, outpatient facility, or crisis center). Note this is a composite score. |
Cumulative through 12-month follow up
|
|
Depression Severity
Time Frame: Cumulative 6-month follow up
|
Total scores from the Patient Health Questionnaire (PHQ-9-M) will be used to assess depression severity. |
Cumulative 6-month follow up
|
|
Time from randomization to first suicide related event
Time Frame: Cumulative through 6-month follow up
|
Time of onset to suicide related to event. Dates are collected on CSSRS and CASA when suicidal behavior events occur (CSSRS) and referrals are made to medical or psychiatric inpatient facility, emergency department, outpatient facility, or crisis center. |
Cumulative through 6-month follow up
|
|
Time from randomization to first suicide related event
Time Frame: Cumulative through 12-month follow up
|
Time of onset to suicide related to event. Dates are collected on CSSRS and CASA when suicidal behavior events occur (CSSRS) and referrals are made to medical or psychiatric inpatient facility, emergency department, outpatient facility, or crisis center. |
Cumulative through 12-month follow up
|
|
Frequency of suicide-related events
Time Frame: Cumulative through 6-month follow up
|
Number of suicide related events across sample collected from CSSRS and CASA. |
Cumulative through 6-month follow up
|
|
Frequency of suicide-related events
Time Frame: Cumulative through 12-month follow up
|
Number of suicide related events across sample collected from CSSRS and CASA. |
Cumulative through 12-month follow up
|
|
Aborted Attempts
Time Frame: Cumulative through 6-month follow up
|
Behavior section, aborted (self-interrupted) attempt endorsed for interval covered on CSSRS. |
Cumulative through 6-month follow up
|
|
Aborted Attempts
Time Frame: Cumulative through 12-month follow up
|
Behavior section, aborted (self-interrupted) attempt endorsed for interval covered on CSSRS. |
Cumulative through 12-month follow up
|
|
Interrupted Attempts
Time Frame: Cumulative through 6-month follow up
|
Behavior section, interrupted attempt endorsed for interval covered on CSSRS. |
Cumulative through 6-month follow up
|
|
Interrupted Attempts
Time Frame: Cumulative through 12-month follow up
|
Behavior section, interrupted attempt endorsed for interval covered on CSSRS. |
Cumulative through 12-month follow up
|
|
Actual attempt (non-fatal)
Time Frame: Cumulative through 6-month follow up
|
Behavior section, actual attempt endorsed for the interval covered on CSSRS. |
Cumulative through 6-month follow up
|
|
Actual attempt (non-fatal)
Time Frame: Cumulative through 12-month follow up
|
Behavior section, actual attempt endorsed for the interval covered on CSSRS. |
Cumulative through 12-month follow up
|
|
Preparatory acts taken for a suicide attempt
Time Frame: Cumulative through 6-month follow up
|
Suicidal behavior indicator endorsed for preparatory acts or behavior toward imminent suicidal behavior endorsed for the interval covered on CSSRS. |
Cumulative through 6-month follow up
|
|
Preparatory acts taken for a suicide attempt
Time Frame: Cumulative through 12-month follow up
|
Suicidal behavior indicator endorsed for preparatory acts or behavior toward imminent suicidal behavior endorsed for the interval covered on CSSRS. |
Cumulative through 12-month follow up
|
|
Emergency referral for increased suicidal ideation
Time Frame: Cumulative through 6-month follow up
|
Study emergency referral recorded in connection with increased suicidal ideation. |
Cumulative through 6-month follow up
|
|
Emergency referral for increased suicidal ideation
Time Frame: Cumulative through 12-month follow up
|
Study emergency referral recorded in connection with increased suicidal ideation. |
Cumulative through 12-month follow up
|
|
Emergency referral for increased suicidal ideation
Time Frame: Cumulative through 6-month follow up
|
Designated CASA emergency referral items where the referral is suicide related (on items related to receipt of treatment from a medical or psychiatric inpatient facility, emergency department, outpatient facility, or crisis center). |
Cumulative through 6-month follow up
|
|
Emergency referral for increased suicidal ideation
Time Frame: Cumulative through 12-month follow up
|
Designated CASA emergency referral items where the referral is suicide related (on items related to receipt of treatment from a medical or psychiatric inpatient facility, emergency department, outpatient facility, or crisis center). |
Cumulative through 12-month follow up
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Service utilization
Time Frame: Baseline
|
Frequency and type of concurrent psychiatric services will be measured through the Child and Adolescent Services Assessment (CASA).The CASA is a semi-structured face-to-face interview. The interview mixes close-ended questions that are often answered by "yes" or "no" with open-ended questions that allow elaboration. The CASA is comprised of four sections: The Child Health Services Screen, The Detailed Child Services Form, Attitudes Toward Services for Children and Adolescents, and Family Demographic and Financial Information (in the parent version only). |
Baseline
|
|
Service utilization
Time Frame: 6-month follow up
|
Frequency and type of concurrent psychiatric services will be measured through the Child and Adolescent Services Assessment (CASA).The CASA is a semi-structured face-to-face interview. The interview mixes close-ended questions that are often answered by "yes" or "no" with open-ended questions that allow elaboration. The CASA is comprised of four sections: The Child Health Services Screen, The Detailed Child Services Form, Attitudes Toward Services for Children and Adolescents, and Family Demographic and Financial Information (in the parent version only). |
6-month follow up
|
|
Service utilization
Time Frame: 12-month follow up
|
Frequency and type of concurrent psychiatric services will be measured through the Child and Adolescent Services Assessment (CASA).The CASA is a semi-structured face-to-face interview. The interview mixes close-ended questions that are often answered by "yes" or "no" with open-ended questions that allow elaboration. The CASA is comprised of four sections: The Child Health Services Screen, The Detailed Child Services Form, Attitudes Toward Services for Children and Adolescents, and Family Demographic and Financial Information (in the parent version only). |
12-month follow up
|
|
Safety planning and BRITE app use
Time Frame: Post-intervention-through 3 months (adolescents & caregivers)
|
Use of the technical components of interventions and web portals of iCHART including: the number and proportion of adolescents, parents, and providers who have engaged with the application components over time and reported pre- and post- updates to the intervention app and web portals:
|
Post-intervention-through 3 months (adolescents & caregivers)
|
|
Intervention Acceptability
Time Frame: Post-intervention-1 month follow up (adolescents, caregivers)
|
Acceptability of the iCHART intervention will be assessed through the 4 item Acceptability of Intervention Measure (AIM). Scales can be created for by averaging responses. Scale values range from 1 to 5. Higher scores indicate greater acceptability. The items include questions to determine if intervention is appealing to, liked by, welcomed by, and approved by study population. |
Post-intervention-1 month follow up (adolescents, caregivers)
|
|
Intervention Usability
Time Frame: Post-intervention-1 month follow up (adolescents, caregivers)
|
Usability of the iCHART intervention will be assessed through the Post System Satisfaction Usability Questionnaire (PSSUQ). PSSUQ follows a 7-point Likert Scale (+ NA option). The overall result is calculated by averaging the scores from the 7 points of the scale. It also has 3 sub-scales, namely system usefulness, information quality, and interface quality. The sub-scales provide a more detailed breakdown of different factors affecting the intervention. PSSUQ score starts with 1 (strongly agree) and ends with 7 (strongly disagree). The lower the score, the better the performance and satisfaction. |
Post-intervention-1 month follow up (adolescents, caregivers)
|
|
Intervention Feasibility
Time Frame: Post-intervention-1 month follow up (adolescents, caregivers)
|
Feasibility of the iCHART intervention will be assessed through the 4 item Feasibility of Intervention Measure (FIM). Scales can be created for by averaging responses. Scale values range from 1 to 5. Higher scores indicate greater feasibility. The items include questions to determine if intervention is easy to use and seems possible or doable to implement in study population. |
Post-intervention-1 month follow up (adolescents, caregivers)
|
|
Intervention Appropriateness
Time Frame: Post-intervention-1 month follow up (adolescents, caregivers)
|
Intervention appropriateness of the iCHART intervention will be assessed through 4 item Intervention Appropriateness Measure (IAM). Scales can be created for by averaging responses. Scale values range from 1 to 5. Higher scores indicate greater appropriateness. The items include questions to determine if intervention is a good match, fitting, suitable, or seems applicable to the study population. |
Post-intervention-1 month follow up (adolescents, caregivers)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Stephanie Stepp, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- STUDY22020069
- P50MH115838 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All requests for study data will follow NIMH's data sharing and data use policies. The final completely de-identified dataset(s) will include demographic and clinical data at baseline, and primary and secondary outcomes for all studies, including those funded by the innovation contests. These analytic datasets may also include derived variables with documentation. Our form datasets will include original case report forms, a detailed codebook of variable names, value labels, and programming formats and all study documentation including the protocol and manual of procedures. For descriptive/raw data, study investigators/study staff will upload to NIMH's National Database for Clinical Trials Related to Mental Health Illness (NDCT) on a semi-annual basis all analyzed data being uploaded prior to primary paper publication.
IPD Sharing Time Frame
Beginning 3 months and ending 5 years following "main outcomes" article publications.
IPD Sharing Access Criteria
In addition to public access to the NDCT, proposals should be directed to georgeba2@upmc.edu. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.